Navigation Links
Researchers Develop An Electric Device For Relief From Migraine

US research have suggested that an electronic device may help 'zap' away migraine pain before it starts, explaining that the hand-held device creates a short-lived electromagnetic field which 'interrupts' the migraine. //

Researchers have explained at the American Headache Society about a device was effective in treating nausea, noise and light sensitivity, which could help in migraine. The researchers from the UK have cautioned that though the finding was interesting it would be safer to test it first in a larger study.

Migraine headaches are often described by people as seeing showers of shooting stars, zigzagging lines and flashing lights, and experiencing loss of vision, weakness, tingling or confusion. These neural disturbances are often the sign of he onset of migraine.

It was explained that the device, called TMS, delivers a strong electric current through a metal coil that creates a strong magnetic field for about one millisecond. This electrical charge is theorised to interrupt the neural phase of migraine before it starts to produce a headache. It was explained that currently patients are given painkillers or triptans as treatment, and they mainly treat the cause rather than the symptom.

The researchers said that of the 23 patients who were treated with the TMS device, 69% of them had reported to have either mild or no pain two hours after as compared with the 48% in the placebo group. And 42% of the TMS-treated patients graded their lack of symptoms as very good or excellent when compared to 26% for placebo. Majority of TMS treated patients felt that they had no noise sensitivity, while more them half felt no light sensitivity, 88% of them felt no nausea when compared with 56% who were treated with some dummy device.

Dr Yousef Mohammad, a neurologist at Ohio State University Medical Center and the lead researcher said: "Perhaps the most significant effect of using the TMS device was on the two-ho
'"/>




Page: 1 2

Related medicine news :

1. Researchers urge caution in using ear tube surgery
2. Researchers Scale to assess the Severity of Epilepsy in Kids
3. Researchers trick Alzheimers Enzyme
4. Researchers find new HIV hiding place
5. New Hair in 15 Days Could Now Be A Possibility Say Researchers
6. Researchers developed world’s smallest toothbrus
7. Researchers discover receptor cells that can cause epilepsy
8. 15 Anti-SARS Drugs Identified By China-Europe Team of Researchers
9. Researchers reversed the process of memory loss
10. Researchers Identify Key Gene That May Help Brain Treatment
11. Researchers Discover Protein That Causes Malaria
Post Your Comments:
(Date:12/5/2009)...ake steps to eliminate triggers, experts advise , ...y,re not Scrooges, but people with allergies and a...aditions and need to take special steps to prevent...College of Allergy, Asthma and Immunology (ACAAI)....hoose to decorate with artificial plants, but both...
(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W
(Date:12/4/2009)PEMBROKE, Bermuda, Dec. 4 Allied World Assurance,Company Holdings, Ltd (NYSE: AWH ) today announced that Scott Carmilani,President and Chief Executive Officer, and Jack Sennott, Executive Vice,Pres
(Date:12/4/2009)ANAHEIM, Calif., Dec. 4 Pamela Bowen, Chief Information Officer at Crescent Healthcare, was selected as a finalist for the "Chief Innovation Officer" Appy Award for transforming Crescent,s business w
(Date:12/4/2009)Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accuratel
Breaking Medicine News(10 mins):Health News:Keep Asthma, Allergies at Bay for the Holidays 2Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3
...Is to Educate Patients and Others about Opportunit...ctal Cancer, ANNAPOLIS, Md., Sept. 4 The Nationa...g and Care announced the appointment of,Randall H....logy Associates, LLC states, "We are pleased to ha...
... --- There,s no magic bullet for wiping out malari...hod that effectively delays the evolution of drug ...lorida researcher says. , David Smith, associate ... current artemisinin-based malaria drugs combined ...
...SAFC Pharma(TM), a focus,area within SAFC(R) ( htt...drich(R) Group (Nasdaq: SIAL ), today officially ...to its Madison (Wisconsin) facility,designed to si...chase of 15 acres of green space in Verona (Wiscon...
...ed Organic and Fair Trade-Certified Drink Featured... Products, NEWTOWN, Pa., Sept. 3 Steaz, the prem...-Certified beverages, has been included on,Women,s...gnizing Steaz, Women,s Health notes consumers can ...
...al, levels triple risk of aggressive disease , ...whose serum calcium levels fall within the high en...to develop fatal prostate cancer, a new report sho...ading too much into the study, given the relativel...
... In July, Christine Demers and Areeba Sadiq ...e and the research coordinator at The Feinstein In...ves but they were going West in search of the seru...q set off for a family reunion in Arkansas. The nu...
Other Medicine News:Health News:National Coalition for Quality Colorectal Cancer Screening and Care Appoints New Executive Director, Randall H. H. Madry: 2Health News:Study: Delaying evolution of drug resistance in malaria parasite possible 2Health News:Study: Delaying evolution of drug resistance in malaria parasite possible 3Health News:SAFC Pharma(TM) Commits to Major Expansion of High Potency API Production at Madison Site 2Health News:SAFC Pharma(TM) Commits to Major Expansion of High Potency API Production at Madison Site 3Health News:Steaz Named to Women's Health List of 125 Best Packaged Foods for Women 2Health News:Study Links Serum Calcium, Prostate Cancer Death 2Health News:Study Links Serum Calcium, Prostate Cancer Death 3Health News:Feinstein Institute: Researching a Family Tree of Autoimmune Disorders 2Health News:Feinstein Institute: Researching a Family Tree of Autoimmune Disorders 3Health News:Feinstein Institute: Researching a Family Tree of Autoimmune Disorders 4Health News:Feinstein Institute: Researching a Family Tree of Autoimmune Disorders 5
(Date:12/3/2009)NEW YORK, Dec. 3 Guidepoint Global, LLC , a leading primary research firm, today announced the launch of their Sleep Apnea Tracker, a monthly longitudinal data release that monitors and projects tre
(Date:12/3/2009)SUNNYVALE, Calif., Dec. 3 Pharmacyclics, Inc. (Nasdaq: PCYC ), a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of immune media
(Date:12/3/2009)WILMINGTON, Del., Dec. 3 ParagonRx, a Delaware-based company specializing in pharmaceutical risk management and optimal medication use, will host a free webinar on Wednesday, Dec. 9, on the FDA,s dra
Breaking Medicine Technology:Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2Reportlinker Adds Cardiac Defibrillators A Worldwide Market Intelligence Report 6603 1Reportlinker Adds Cardiac Defibrillators A Worldwide Market Intelligence Report 6603 2Reportlinker Adds Cardiac Defibrillators A Worldwide Market Intelligence Report 6603 3Reportlinker Adds Cardiac Defibrillators A Worldwide Market Intelligence Report 6603 4Reportlinker Adds Cardiac Defibrillators A Worldwide Market Intelligence Report 6603 5Reportlinker Adds Cardiac Defibrillators A Worldwide Market Intelligence Report 6603 6Reportlinker Adds Cardiac Defibrillators A Worldwide Market Intelligence Report 6603 7Reportlinker Adds Cardiac Defibrillators A Worldwide Market Intelligence Report 6603 8Reportlinker Adds Cardiac Defibrillators A Worldwide Market Intelligence Report 6603 9Reportlinker Adds Cardiac Defibrillators A Worldwide Market Intelligence Report 6603 10Reportlinker Adds Cardiac Defibrillators A Worldwide Market Intelligence Report 6603 11Reportlinker Adds Cardiac Defibrillators A Worldwide Market Intelligence Report 6603 12Reportlinker Adds Cardiac Defibrillators A Worldwide Market Intelligence Report 6603 13MedQuist Features SpeechQ VTB for Radiology Solution at RSNA Convention 6597 1MedQuist Features SpeechQ VTB for Radiology Solution at RSNA Convention 6597 2eHealthSource com Launches Online Shopping Site Dedicated to Over the Counter Medications Approved for FSA HSA Claims 6590 1eHealthSource com Launches Online Shopping Site Dedicated to Over the Counter Medications Approved for FSA HSA Claims 6590 2
...N, South Korea, Jan. 12 Jennerex,Inc. (San Franci... partner,Green Cross Corp., today announced treatm...y liver cancer clinical trial using its targeted a...s were reported, and enrollment of,patients onto t...volves treatment of patients with advanced, primar...
...Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ), a ... and development of drugs for the treatment of hum...unced that it has initiated a proof-of-concept stu...candidate for the treatment of HCV under an Invest... Food and Drug Administration (FDA). The study is ...
Other Medicine Technology:Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer 2Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer 3Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer 4Idenix Pharmaceuticals Initiates Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV) 2Idenix Pharmaceuticals Initiates Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV) 3Idenix Pharmaceuticals Initiates Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV) 4
Creatine Kinase (CK-NAC)
Alanine Aminotransferase (ALT) GPT
Alkaline Phosphatase (ALP) (DIMENSION)
...ost other EMR,systems require you to,change th...c patient charting,solution designed to fit into...round,five specific criteria to,enhance overal...oPad allows you to see,more patients in the same...
Medicine Products: